PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
01-Feb-2024 Bedless Hospitals Market Charts a Remarkable Ten-Year Projection of Value from 2023 to 2033 MARKITWIRED
01-Feb-2024 3D Imaging Surgical Solutions Market Envisioning a Future Valued at US$ 263.9 Million by 2033 MARKITWIRED
01-Feb-2024 Veterinary Antibiotic Market Primed to Soar Past US$ 20,154.0 Million by 2033 MARKITWIRED
01-Feb-2024 3D-Printed Maxillofacial Implants Market Aims to Surpass US$ 1,119.1 Million by 2033 MARKITWIRED
01-Feb-2024 Vaginal Specula Market Gears Up for Explosive Growth, Projected to Exceed US$ 1,301.5 Million by 2033 MARKITWIRED
01-Feb-2024 Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference AccessWire
31-Jan-2024 Moderna Named to Fortune's List of World's Most Admired Companies AccessWire
31-Jan-2024 Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset AccessWire
31-Jan-2024 AltaThera Pharmaceuticals at AF Symposium 2024 AccessWire
31-Jan-2024 First Stop Health Announces Appointment of New Board Members AccessWire
31-Jan-2024 Bikham Healthcare Launches Provider Passport AccessWire
31-Jan-2024 Biotics Research Announces Partnership With Ananda Professional for Premium Hemp Solutions AccessWire
31-Jan-2024 Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health AccessWire
31-Jan-2024 Stemtech Corporation Expands Global Reach with New License Agreement in Africa AccessWire
31-Jan-2024 Ludwig Enterprises mRNA Bladder Cancer Study to be Launched AccessWire
31-Jan-2024 Study Unlocks New Hope in the Battle Against Male Infertility AccessWire
31-Jan-2024 Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules AccessWire
31-Jan-2024 Renalogic Partners With AmeriHealth Administrators to Address High-Cost Dialysis Claims for the Marketplace AccessWire
31-Jan-2024 Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain AccessWire
31-Jan-2024 Open Letter to Zomedica Shareholders from your Chief Executive Officer AccessWire